一种新型还原性壳聚糖吸附剂的制备研究

以壳聚糖为原料,利用Mannich反应原理,在壳聚糖分子的氨基上引入具有还原性能的亚磷酸基团,制备出新型还原性壳聚糖吸附剂RCA,并考察其对Cr(VI)的还原吸附效果。研究结果表明,当反应温度为80℃,戊二醛用量为45.0%,亚磷酸用量为30.0%,反应时间为2h时,制得的还原性壳聚糖吸附剂对Cr(VI)的还原吸附率为94.8%。此外,该吸附剂具有较强的耐酸碱能力和抗氧化能力。红外光谱分析和元素分析结果表明,壳聚糖分子上已成功引入亚磷酸基团。     

双活性磺酸基蔗渣木聚糖对羟基苯甲酸酯的合成及活性模拟

以蔗渣木聚糖(BX)为主要原料、氨基三磺酸钠为酯化剂,在一步酯化合成磺酸基蔗渣木聚糖酯的基础上,利用磺酸基蔗渣木聚糖酯和对羟基苯甲酸进行二步酯化反应,合成了磺酸基蔗渣木聚糖对羟基苯甲酸酯,并考察了反应条件对酯化反应的影响,通过单因素实验确定了第二步酯化反应较佳的合成工艺条件.蔗渣木聚糖酯化改性前后的样品分别用FT-IR,DG-DTG和XRD进行了表征,并对该双酯化衍生物的分子进行了优化与活性模拟.结果表明:FT-IR证明双酯化产物含有磺酸基团和对羟基苯甲酸酯基团,TG-DTG分析表明该双酯化衍生物的热稳定性提高,XRD说明发生双酯化改性后分子排列的规整性提高,结晶度增加;活性模拟实现了磺酸基蔗渣木聚糖对羟基苯甲酸酯与艾滋病毒的对接.     

共价键合多层肝素薄膜修饰涂有硅橡胶的人工血管

报道一种采用医用硅橡胶涂层作软支撑共价键合多层肝素薄膜修饰人工血管等生物医学装置使其表面具有抗凝血性能的方法. 该项技术首先在人工血管的表面上涂上医用硅橡胶作为软支撑, 再在硅橡胶涂层的表面上涂上全氟磺酸(Nafion), 为接下来的层层静电组装提供活性基团. 然后将带正电荷的二苯胺重氮树脂(PA)和带负电荷的肝素分子(Hep)通过静电吸引作用交替沉积到全氟磺酸涂层的表面上. 紫外可见吸收光谱和傅立叶红外光谱数据表明, 在紫外光照射下, 重氮树脂的重氮基团与肝素的硫酸基团之间发生光化学反应, 生成硫酸酯, 使膜内层间离子键转变成共价键, 从而使肝素多层膜的稳定性大大提高. 研究表明经层层自组装和光化学反应后肝素分子呈现良好的抗凝血性能. 人工血管肝素化表面中的肝素分子以壁面结合的方式存在, 在人工血管表面固化肝素和抗凝血酶-III (AT-III)形成的络合物显示出较好的抗凝血性. 硅橡胶涂层使肝素分子与人工血管表面有一定距离, 有利于提高抗凝血性能. 在四个双层之内, 肝素对凝血酶失活的影响随着PA/Hep双层数目增加而增加, 说明了只有最外层的肝素才对凝血酶失活有直接影响. 该方法操作工艺简单, 重复性好, 可较广泛地适用于在多种生物医用装置和多孔组织工程支架材料的表面制备稳定的抗凝血涂层, 具有良好的应用前景.     

负载壳聚糖及其衍生物的材料表面血液相容性研究进展

壳聚糖及其衍生物具有多种生物活性,基于壳聚糖及其衍生物的材料表面改性是获取各种生物活性表面的重要手段,在生物材料领域显示出广阔的应用前景。为了获得血液相容性良好的壳聚糖改性生物材料表面,可通过引入具备抗凝活性的壳聚糖衍生物或壳聚糖/抗凝剂复合物来抑制壳聚糖固有的促凝作用。本文综述了负载有壳聚糖或其衍生物的材料表面的血液相容性改性方法方面的进展,并根据表面改性方法的不同按照物理改性和化学改性分别对其进行了阐述。     

纤维素基吸附分离材料研究进展

以纤维素为原料制备吸附分离材料可以减少对石油资源的依赖,并具有成本低、环境友好和生物相容性好等优点。利用纤维素中的羟基基团,通过交联、接枝、引入无机粒子或与聚合物复合,可以制备出微球和薄膜等不同形态的吸附分离材料,广泛应用于生物医学,废水处理、气体分离等领域。本文结合近五年来国内外纤维素及其复合材料在吸附分离领域的研究近况,从水、油、重金属、气体和有机物的应用进行了综述,总结了纤维素基吸附分离材料的研究尚存在的问题,探讨了今后的研究方向。     

引入离子基团改善聚苯乙烯与热致液晶聚合物的相容性Ⅱ.用FTIR研究分子间特殊相互作用

向聚苯乙烯(PS)中引入磺酸基团可以有效地改善PS与一种热致液晶聚合物(LCP)之间的相容性.用溶液共混的方法制备了PS和磺化聚苯乙烯(HSPS)与LCP的共混物.用FTIR以及红外光谱的合成技术对LCP共混体系进行了表征.共混物中组分聚合物特征吸收的位置和谱图的形状表明在LCP与PS分子间没有相互作用发生,而在LCP与HSPS分子间则存在较强的相互作用.谱图差减技术确认了LCP分子中C==O与C--O基团和HSPS中的磺酸基团参与了相互作用,使得这些基团的特征吸收发生了偏移.     

具有高效长侧链的芘磺酸型磺化聚砜阳离子交换膜的性能

以双酚A型聚砜和无致癌毒性的溴甲基化试剂1,4-二溴丁烷为原料,通过烷基化反应在聚砜分子上引入可交换溴原子制备溴代聚砜(BPSF),将BPSF与8-羟基-1,3,6-芘三磺酸钠(TS)试剂通过亲核取代反应制备一种磺酸基团远离聚合物主链的芘磺酸型磺化聚砜(PS-TS)。采用溶液流延法制备PS-TS阳离子交换膜,通过控制亲核取代反应的时间制备了一系列磺酸基团含量不同的磺化聚砜膜PS-TS-n(PSF-TS-1(0.79 mmol/g)、PSF-TS-2(1.01 mmol/g)、PSF-TS-3(1.28 mmol/g))。结果表明,由于亲疏水区域距离较远,形成的相分离程度明显,PSF-TS膜在高吸水率下仍能保持很好的尺寸稳定性,随着磺酸基团含量增多,相分离程度增强,其中磺酸基团含量为1.32 mmol/g的PSF-TS-3膜在25和85℃的溶胀率仅为22.9%和51.3%,相应的质子传导率达到了0.088和0.149 S/cm,尺寸稳定性超过了商业化Nafion115膜在相同条件下的性能,有望用于燃料电池的实际应用。     

离子对反相薄层色谱法分离碱性染料

Lepri等首先用离子对技术研究了18种水溶性食品染料在氯化十二烷基吡啶浸渍的硅烷化硅胶薄层板上的色谱行为.随后Ruijten指出,离子对反相色谱技术对手芳香化合物和脂肪化合物中离解基团的鉴定是一种有效的手段,化合物中的R值与分子中各种基团(羧酸基、磺酸基、胺基等)数目和位置相关。在染料分子中多含有磺酸基、羧酸基或伯、仲、叔的胺基。因而,离子对反相色谱技术对它们的分离特别有用。我们曾用苯基键合板以溴化四丁基胺为反离子,成功地分离了四种酸性食品染料。本文用甲基苯乙基二氯硅烷与硅胶G预涂板反应,制备了一种新的键合板,用于分离碱性染料效果良好。     

壳聚糖及其衍生物在组织工程中的应用

壳聚糖由于具有良好的生物相容性、生物可降解性以及具有可反应的活性基团,因而在生物、医学等领域具有广泛的研究和应用。随着组织工程学研究的深入,壳聚糖及其衍生物材料作为天然高分子组织工程支架越来越受到重视,综述了近年来国内外壳聚糖及其衍生物在组织工程上的研究和应用情况,包括壳聚糖及其衍生物支架材料的制备方法、壳聚糖的改性以及壳聚糖复合材料等。     

环氧化天然橡胶二次改性的研究进展

环氧化天然橡胶(ENR)分子链中存在易开环的反应性环氧基团,环氧基团的开环反应为ENR进行进一步的改性提供了极大的方便。ENR选择性氢化双键可以提高其抗热氧稳定性;ENR与胺类化合物和含磷化合物的反应,可以将防老剂和阻燃剂负载到ENR分子链上,从而达到在分子尺寸的分散;可以利用环氧基团的选择性氧化裂解制备NR基嵌段共聚物的前驱体遥爪型NR;通过环氧基团可以进行接枝改性其它聚合物;此外,分子链中的环氧基团使ENR与无机填料和其它极性聚合物共混相容性提高。     

Protein adsorption and platelet adhesion of polysulfone membrane immobilized with chitosan and heparin conjugate

Polysulfone (PSF) membranes were treated with ozone to introduce peroxides, and then grafted with either acrylic acid or chitosan, followed by the immobilization of heparin. The effect of spacer arm on blood compatibility was investigated using three chitosans of different molecular weight [1170 (water soluble), 160 000, and 400 000] and similar degrees of deacetylation (75%). The hydrophilicity was evaluated by measuring the contact angle of water. Blood compatibility was evaluated using the activated partial thromboplastin time (APTT) as well as the adhesion of platelets. The protein affinity was determined by the absorption of human serum albumin (HSA) and human plasma fibrinogen (HPF). The results show that by the coupling of chitosan, the amount of heparin immobilized can be increased by four times. Water contact angle (from 78 ° to 41 °) decreased with the increase of the amount of heparin immobilized, showing increased wettability. The heparinized PSF membrane showed longer APTT and decreasing platelet adhesion, compared to that of unmodified PSF membrane. The adsorption of HSA and HPF were reduced to 17 and 6%, respectively. This suggests that longer spacer binding to heparin can increase the opportunity of anti‐coagulation on contacting blood. These results demonstrated that the hydrophilicity and blood compatibility of PSF membrane could be improved by chitosan and heparin conjugate. Copyright © 2003 John Wiley & Sons, Ltd.     

Adsorption of doxorubicin on poly(methyl methacrylate)-chitosan-heparin-coated activated carbon beads

Extracorporeal filter cartridges, filled with an activated carbon bead (ACB) adsorbent, have been used for removal of overdosed cancer drugs from the blood. Coatings on adsorbent matrices, poly(methyl methacrylate) (PMMA)/activated carbon bead and PMMA/chitosan/heparin/ACB composites, were tested to improve their biocompatibility and blood compatibility. PMMA coating on ACBs was accomplished in a straightforward manner using a PMMA solution in ethyl acetate. A one-step hybrid coating of ACBs with PMMA-anticoagulant heparin required the use of acetone and water co-solvents. Multilayer coatings with three components, PMMA, chitosan, and heparin, involved three steps: PMMA was first coated on ACBs; chitosan was then coated on the PMMA-coated surface; and finally, heparin was covalently attached to the chitosan coating. Surface morphologies were studied by scanning electron microscopy. X-ray photoelectron spectroscopy confirmed the -SO(3)(-) group. Adsorption, of a chemotherapy drug (doxorubicin) from both water and phosphate-buffered saline, by the coated ACBs was examined. The adsorption isotherm curves were fitted using the Freundlich model. The current adsorption system might find potential applications in the removal of high-dose regional chemotherapy drugs while maintaining high efficiency, biocompatibility, and blood compatibility.     

肝素化壳聚糖季铵盐／壳聚糖复合膜抗凝血性能的研究

以壳聚糖季铵盐，壳聚糖为基本原材料，选用戊二醛为交剂剂及固定剂，制备一种物理机械性能较优的抗凝血材料。探讨了戊二醛及肝素钠两者用量对肝素化程度及血液生的影响。     

Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials

We developed chitosan based surfactant polymers that could be used to modify the surface of existing biomaterials in order to improve their blood compatibility. These polymers consist of a chitosan backbone, PEG side chains to repel non-specific protein adsorption, and hexanal side chains to facilitate adsorption and proper orientation onto a hydrophobic substrate via hydrophobic interactions. Since chitosan is a polycationic polymer, and it is thrombogenic, the surface charge was altered to determine the role of this charge in the hemocompatibility of chitosan. Charge had a notable effect on platelet adhesion. The platelet adhesion was greatest on the positively charged surface, and decreased by almost 50% with the neutralization of this charge. A chitosan surface containing the negatively charged SO(3)(-) exhibited the fewest number of adherent platelets of all surfaces tested. Coagulation activation was not altered by the neutralization of the positive charge, but a marked increase of approximately 5-6 min in the plasma recalcification time (PRT) was displayed with the addition of the negatively charged species. Polyethylene (PE) surfaces were modified with the chitosan surfactant resulting in a significant improvement in blood compatibility, which correlated to the increasing PEG content within the polymer. Adsorption of the chitosan surfactants onto PE resulted in approximately an 85-96% decrease in the number of adherent platelets. The surfactant polymers also reduced surface induced coagulation activation, which was indicated by the PEG density dependent increase in PRTs. These results indicate that surface modification with our chitosan based surfactant polymers successfully improves blood compatibility. Moreover, the inclusion of either negatively charged SO(3)(-) groups or a high density of large water-soluble PEG side chains produces a surface that may be suitable for cardiovascular applications.     

基于多巴胺自聚合及肝素固定改善钛的血液相容性

利用多巴胺自聚合及肝素固定的方法对纯钛进行表面修饰, 以改善其血液相容性. 采用水接触角测量、 X射线光电子能谱(XPS)和甲苯胺蓝法(TBO)等方法对所修饰的材料进行了表征. 采用溶血实验检测了材料的溶血性能, 并结合活化部分凝血活酶时间(APTT)测试和血小板黏附实验对所修饰材料的血液相容性进行了评价. 结果表明, 多巴胺能够在钛表面实现自聚合, 肝素可以共价接枝在聚多巴胺层上, 经肝素修饰后的材料的表面亲水性显著提高, 而且具有较低的溶血率, APTT时间显著延长, 血小板的黏附数量和被激活程度也显著降低. 因此, 纯钛经多巴胺自聚合以及肝素接枝修饰后的血液相容性得到了显著改善, 有望成为具有抗凝血功能的新型心血管植入材料.     

聚对亚苯基二亚甲基薄膜的表面化学改性及其肝素化反应

采用化学气相沉积聚合(CVDP)法制备聚对亚苯基二亚甲基(PPX),再通过与酸酐的化学表面反应将丁酸酰基和马来酰基引入PPX薄膜的表面,制得表面带活性取代基的PPX.改性后的薄膜表面粗糙度略有增加,但仍旧维持在10nm以内.改性后的薄膜水接触角减小,减小幅度达到十几度,表面亲水性大幅度提高.丁二酸酐表面改性后薄膜的抗化学氧化时间不变,马来酸酐表面改性后薄膜的抗氧化时间略有下降,但抗氧化时间都大于30h,仍具有优异的抗化学氧化性能.丁酸酰基和马来酰基取代PPX肝素化反应后膜中的肝素含量在7μg/cm2左右,肝素化后薄膜的抗凝血性能得到明显提高.     

肝素化聚甲基硅氧烷-聚氧乙烯接枝物的合成及其体外抗凝血性能评价

以二甲基硅油接枝端羟基聚氧乙烯（ＰＤＭＳ ｇ ＰＥＯ ＯＨ）为基材，用二环己基碳二亚胺（ＤＣＣＩ）作脱剂，研究了羟基（ＯＨ）与肝素上的羧基（—ＣＯＯＨ）之间的脱水缩合反应，制备出肝素化的抗血栓材料ＰＤＭＳ ｇ ＰＥＯ Ｈｅｐ，并对其涂覆表面的肝素含量和体外抗凝血性能进行了初步评价．实验结果表明，肝素接枝的共聚物具有优良的抗凝血性能和一定的应用前景．     

Biomimetic modification of chitosan with covalently grafted lactose and blended heparin for improvement of in vitro cellular interaction

Lactose‐ and heparin‐modified chitosan films were prepared and their physical and biological properties were compared with chitosan, chitosan‐g‐heparin, and chitosan‐g‐lactose films. Atomic force microscopy (AFM) measurement showed that all these films in the dry state were rather flat with a roughness smaller than 20 nm. While the chitosan‐g‐lactose/heparin and chitosan‐g‐lactose films have the highest swelling and weight loss ratios, the chitosan and chitosan‐g‐heparin films have the lowest. The chitosan‐g‐lactose/heparin film showed stronger ability to induce chondrocyte attachment, proliferation, viability, and glycosaminoglycan (GAG) secretion than that of the chitosan, chitosan‐g‐heparin, and chitosan‐g‐lactose films. Chondrocyte aggregates and nodules were observed on the chitosan‐g‐lactose/heparin and chitosan‐g‐lactose films, which still preserved viable metabolic ability. These results show that the lactose‐modified and heparin‐incorporated chitosan film can enhance the cell–biomaterial interaction synchronously. The resulting chitosan‐g‐lactose/heparin material is more bioactive that might be applicable as promising scaffold for chondrogenesis. Copyright © 2007 John Wiley & Sons, Ltd.     

Grafting of 18β-Glycyrrhetinic Acid and Sialic Acid onto Chitosan to Produce a New Amphipathic Chitosan Derivative: Synthesis,Characterization, and Cytotoxicity

Chitosan is the only cationic polysaccharide found in nature. It has broad application prospects in biomaterials, but its application is limited due to its poor solubility in water. A novel chitosan derivative was synthesized by amidation of chitosan with 18β-glycyrrhetinic acid and sialic acid. The chitosan derivatives were characterized by Fourier transform infrared spectroscopy, thermogravimetric analysis, and measurement of the zeta potential. We also investigated the solubility, cytotoxicity, and blood compatibility of chitosan derivatives. 18β-glycyrrhetinic acid and sialic acid could be grafted onto chitosan molecular chains. The thermal stability of the synthesized chitosan derivatives was decreased and the surface was positively charged in water and phosphate-buffered saline. After chitosan had been modified by 18 β-glycyrrhetinic acid and sialic acid, the solubility of chitosan was improved greatly in water and phosphate-buffered saline, and percent hemolysis was <5%. Novel amphiphilic chitosan derivatives could be suitable polymers for biomedical purposes.     

Characterization and antibacterial activity of chitosan‐based composites with polyester

The effects of replacing poly(butylene succinate adipate) (PBSA) with acrylic acid‐grafted PBSA (PBSA‐g‐AA) on the structure and the properties of a PBSA/chitosan composite were investigated. The properties of both PBSA‐g‐AA/chitosan and PBSA/chitosan were compared using Fourier transform infrared (FTIR), ¹³C nuclear magnetic resonance (NMR), X‐ray diffraction (XRD), and an antibacterial activity test. With PBSA‐g‐AA in the composite, the compatibility with chitosan and, consequently, the properties of the composite became greatly improved due to the formation of ester and imide groups that conferred better dispersion and homogeneity of chitosan in the matrix. Composites containing PBSA‐g‐AA/chitosan exhibited superior mechanical properties due to greater compatibility between the two components. Moreover, chitosan enhanced the antibacterial activity of the composites. Composites of PBSA‐g‐AA or PBSA that contain chitosan have better antibacterial activity. The functionalized PBSA‐g‐AA/chitosan composites showed markedly enhanced antibacterial properties due to the carboxyl groups of acrylic acid, which acted as coordination sites for the chitosan phase, allowing the formation of stronger chemical bonds. Copyright © 2011 John Wiley & Sons, Ltd.